Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret; van Thuan Hoang; Jean-Christophe Lagier; Didier Raoult

doi:10.1016/j.ijid.2020.10.005

Journal articles

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret ^{1, 2} van Thuan Hoang ^{1, 2} Jean-Christophe Lagier ^{2, 3} Didier Raoult ^{2, 3}

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes

2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection

3 MEPHI - Microbes évolution phylogénie et infections

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Bacteriology

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Life Sciences [q-bio] / Microbiology and Parasitology / Parasitology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Life Sciences [q-bio] / Human health and pathology / Emerging diseases

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03216101
Contributor : Isabelle Combe <>
Submitted on : Monday, May 3, 2021 - 5:24:23 PM
Last modification on : Tuesday, May 4, 2021 - 3:23:49 AM

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Links full text

Identifiers

Collections

Citation

Export

Metrics

13

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

13